NCT07021820 Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
| NCT ID | NCT07021820 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Erlangen-Nürnberg Medical School |
| Condition | Centronuclear Myopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-29 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-05-29 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Twenty patients with centronuclear myopathy and twenty age- and sex-matched, muscle-healthy controls will undergo diagnostic examination. Study participants will undergo physical examination, clinical and functional testing, and multispectral optoacoustic tomography (MSOT) scanning at predefined muscle sites (paraspinal muscles, trapezius muscle, deltoid muscle, forearm flexors, quadriceps muscle, adductor muscles, ischiocrural muscles, triceps surae muscle, and tibialis anterior).
Eligibility Criteria
CNM arm: Inclusion Criteria: diagnosed CNM; minimum of 2 years of age Exclusion Criteria: * Pregnancy * Nursing mothers * Tattoo in the area of the examination field * Subcutaneous fatty tissue \> 3 cm HV: Inclusion criteria: minimum of 2 years of age Exclusion criteria: * any signs/history of muscle diseases * Pregnancy * Nursing mothers * Tattoo in the area of the examination field * Subcutaneous fatty tissue \> 3 cm
Contact & Investigator
Ferdinand Knieling, PD Dr. med. habil. Dr. rer. b
STUDY CHAIR
Kinder- & Jugendklinik, Erlangen
Frequently Asked Questions
Who can join the NCT07021820 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, studying Centronuclear Myopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07021820 currently recruiting?
Yes, NCT07021820 is actively recruiting participants. Contact the research team at Lina.Tan@uk-erlangen.de for enrollment information.
Where is the NCT07021820 trial being conducted?
This trial is being conducted at Erlangen, Germany.
Who is sponsoring the NCT07021820 clinical trial?
NCT07021820 is sponsored by University of Erlangen-Nürnberg Medical School. The principal investigator is Ferdinand Knieling, PD Dr. med. habil. Dr. rer. b at Kinder- & Jugendklinik, Erlangen. The trial plans to enroll 40 participants.